COUNCIL ON RADIONUCLIDES AND RADIOPHARMACEUTICALS INC
1300 PICCARD DRIVE SUITE LL 14, ROCKVILLE, MD 20850 www.corar.org

Total Revenue
$1,019,441
Total Expenses
$816,406
Net Assets
$1,186,370

Organizations Filed Purposes: CORAR IS THE TRADE ASSOCIATION AND VOICE OF THE RADIONUCLIDES AND RADIOPHARMACEUTICALS INDUSTRY IN NORTH AMERICA. CORAR ADVOCATES FOR PUBLIC POLICIES THAT IMPACT HEALTH CARE, TRANSPORTATION SAFETY, HOMELAND SECURITY, AND MANUFACTURING IN AN EFFORT TO EXPAND ACCESS TO SAFE AND AFFORDABLE HEALTH CARE TREATMENTS FOR ALL.

MONITOR, REPRESENT TO, AND ASSIST PROCATIVELY IN REGULATORY AND LEGISLATIVE PROCESSES TO ENSURE REASONABLE CONTROLS ON THE DEVELOPMENT, MANUFACTURE, TRANPORTATION, USE, SERVICE, AND DISPOSAL OF REDIOACTIVE PRODUCTS. ALSO TO PROMOTE PUBLIC AWARENES OF THE BENEFITS OF SUCH PRODUCTS AND SERVICES TO SOCIETY.

Executives Listed on Filing

Total Salary includes financial earnings, benefits, and all related organization earnings listed on tax filing

NameTitleHours Per WeekTotal Salary
Michael GuastellaEXECUTIVE DIRECTOR40$227,976
David RobertsonDIRECTOR1$0
Eric SchuttDIRECTOR1$0
John FelockDIRECTOR1$0
Larry MullinsDIRECTOR1$0
James HarveyDIRECTOR1$0
Bill ReganDIRECTOR1$0
Michael DuffyDIRECTOR1$0
Norman LafranceDIRECTOR1$0
Chris WagnerDIRECTOR1$0
Jim WilsonDIRECTOR1$0
Hugh EvansDIRECTOR1$0
Roy BrownDIRECTOR1$0
Tiffany OlsonDIRECTOR1$0
Martyn CoombsDIRECTOR1$0
Shaemus GleasonDIRECTOR1$0
Mike RossiDIRECTOR1$0
Ira GoldmanSECRETARY/TREASURER1$0
Steve LaflinVICE CHAIRMAN1$0
David PellicciariniCHAIRMAN1$0

Data for this page was sourced from XML published by IRS (public 990 form dataset) from: https://s3.amazonaws.com/irs-form-990/202100539349300635_public.xml